Antibody-enhanced infection by HIV-1 via Fc receptor-mediated entry.

Monocytes and macrophages, which may play a central role in the pathogenesis of infection with human immunodeficiency virus type 1 (HIV-1), express the CD4 molecule and Fc receptors (FcR) for immunoglobulin G (IgG). To explore the possibility that FcR mediate HIV-1 infection of monocytes, studies were conducted with the human monocytic cell line U937. These cells were exposed to HIV-1 complexed with various concentrations of serum from HIV-1 antibody-positive individuals and monitored for HIV-1 replication. Serum samples from antibody-negative normal individuals did not affect virus yields. High concentrations of antibody-positive sera showed virus-neutralizing activity; however, cells infected with HIV-1 in the presence of antibody-positive sera at subneutralizing concentrations significantly enhanced virus replication. This infection enhancement was blocked by heat-aggregated gamma-globulin. Moreover, the IgG fraction from an HIV-1 antibody-positive serum enhanced HIV-1 infection at the same serum dilution equivalents. In contrast, IgG-F(ab')2 did not enhance HIV-1 infection but showed neutralizing activity with HIV-1. These results are compatible with the concept of FcR-mediated infection enhancement and suggest that this immunological response to HIV-1, instead of protecting the host, potentially facilitates the infection.

[1]  E. Gelmann,et al.  The Acquired Immunodeficiency Syndrome: An Update , 1985 .

[2]  S. Gollins,et al.  Flavivirus infection enhancement in macrophages: radioactive and biological studies on the effect of antibody on viral fate. , 1984, The Journal of general virology.

[3]  W. Bancroft,et al.  Effect of Passage History on Dengue-2 Virus Replication in Subpopulations of Human Leukocytes , 1979, Infection and immunity.

[4]  S. Halstead.  In vivo enhancement of dengue virus infection in rhesus monkeys by passively transferred antibody. , 1979, The Journal of infectious diseases.

[5]  J. Mcdougal,et al.  In vitro infection of human monocytes with human T lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV). , 1986, Journal of immunology.

[6]  S. Halstead,et al.  Pathogenesis of dengue: challenges to molecular biology. , 1988, Science.

[7]  Human T lymphotropic virus type III infection of human alveolar macrophages. , 1986 .

[8]  S. Gollins,et al.  Flavivirus infection enhancement in macrophages: an electron microscopic study of viral cellular entry. , 1985, The Journal of general virology.

[9]  D. Segal,et al.  Binding of affinity cross-linked oligomers of IgG to cells bearing Fc receptors. , 1977, Journal of immunology.

[10]  W. Brandt,et al.  Evidence for two mechanisms of dengue virus infection of adherent human monocytes: trypsin-sensitive virus receptors and trypsin-resistant immune complex receptors , 1981, Infection and immunity.

[11]  S. Salahuddin,et al.  Restricted expression of human T-cell leukemia--lymphoma virus (HTLV) in transformed human umbilical cord blood lymphocytes. , 1983, Virology.

[12]  C. Anderson,et al.  Human monocytes and U937 cells bear two distinct Fc receptors for IgG. , 1986, Journal of immunology.

[13]  S. Halstead,et al.  Antibody-enhanced dengue virus infection in primate leukocytes , 1977, Nature.

[14]  D. Montefiori,et al.  ANTIBODY-DEPENDENT ENHANCEMENT OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 INFECTION , 1988, The Lancet.

[15]  M. Marsh.  The entry of enveloped viruses into cells by endocytosis. , 1984, The Biochemical journal.

[16]  F. Gyorkey,et al.  Human immunodeficiency virus in brain biopsies of patients with AIDS and progressive encephalopathy. , 1987, The Journal of infectious diseases.

[17]  SB Halstead,et al.  Dengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody , 1977, The Journal of experimental medicine.

[18]  F. Chiodi,et al.  Infection of brain-derived cells with the human immunodeficiency virus , 1987, Journal of virology.

[19]  R. Warnke,et al.  Anti-Leu-3/T4 antibodies react with cells of monocyte/macrophage and Langerhans lineage. , 1983, Journal of immunology.

[20]  B. Haynes,et al.  Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS. , 1984, Science.

[21]  R. Gallo,et al.  Detection of lymphocytes expressing human T-lymphotropic virus type III in lymph nodes and peripheral blood from infected individuals by in situ hybridization. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[22]  M. Dietrich,et al.  ALTERED FOLLICULAR DENDRITIC CELLS AND VIRUS-LIKE PARTICLES IN AIDS AND AIDS-RELATED LYMPHADENOPATHY , 1985, The Lancet.

[23]  Luc Montagnier,et al.  T-lymphocyte T4 molecule behaves as the receptor for human retrovirus  LAV , 1984, Nature.

[24]  J. Levy,et al.  AIDS-associated retroviruses (ARV) can productively infect other cells besides human T helper cells. , 1985, Virology.

[25]  M. Greaves,et al.  The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus , 1984, Nature.

[26]  A. Helenius,et al.  On the entry of semliki forest virus into BHK-21 cells , 1980, The Journal of cell biology.

[27]  C. Griscelli,et al.  Selective tropism of lymphadenopathy associated virus (LAV) for helper-inducer T lymphocytes. , 1984, Science.

[28]  M. Hirsch,et al.  Infection of monocyte/macrophages by human T lymphotropic virus type III. , 1986, The Journal of clinical investigation.

[29]  S. Halstead.  The Alexander D. Langmuir Lecture. The pathogenesis of dengue. Molecular epidemiology in infectious disease. , 1981, American journal of epidemiology.

[30]  C. Cheng‐Mayer,et al.  Human immunodeficiency virus can productively infect cultured human glial cells. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[31]  H. Ochiai,et al.  Antibody-mediated growth of influenza A NWS virus in macrophagelike cell line P388D1 , 1988, Journal of virology.

[32]  K. Nilsson,et al.  Establishment and characterization of a human histiocytic lymphoma cell line (U‐937) , 1976, International journal of cancer.

[33]  J. Fujimoto,et al.  Human T lymphocytes and monocytes bear the same Leu-3(T4) antigen. , 1986, Journal of immunology.

[34]  R. Redfield,et al.  The Walter Reed staging classification for HTLV-III/LAV infection. , 1986, The New England journal of medicine.

[35]  J. Schlesinger,et al.  Growth of 17D yellow fever virus in a macrophage-like cell line, U937: role of Fc and viral receptors in antibody-mediated infection. , 1981, Journal of immunology.

[36]  D. Francis,et al.  Immunoassay for the detection and quantitation of infectious human retrovirus, lymphadenopathy-associated virus (LAV). , 1985, Journal of immunological methods.

[37]  C. Anderson,et al.  Human leukocyte IgG Fc receptors. , 1986, Immunology today.

[38]  J. Unkeless,et al.  Monoclonal anti-Fc receptor IgG blocks antibody enhancement of viral replication in macrophages , 1981, Nature.

[39]  J. Clements,et al.  Slow virus replication: the role of macrophages in the persistence and expression of visna viruses of sheep and goats. , 1982, The Journal of general virology.

[40]  J. S. Porterfield,et al.  Antibody-mediated enhancement of Flavivirus replication in macrophage-like cell lines , 1979, Nature.